Ascendis Pharma A/S (ASND)
196.83
+0.20
(+0.10%)
USD |
NASDAQ |
Dec 10, 14:47
Ascendis Pharma Total Assets (Quarterly): 1.357B for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Evaxion AS | 25.24M |
| Novo Nordisk A/S | 80.64B |
| DBV Technologies SA | 110.50M |
| Cellectis SA | 343.04M |
| Biodexa Pharmaceuticals Plc | -- |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.561B |
| Shareholders Equity (Quarterly) | -204.54M |
| Debt to Equity Ratio | -4.674 |
| Current Ratio | 1.032 |
| Net Debt Paydown Yield | -0.39% |